Department of Microbiology and Immunology, University of California-San Francisco and Parker Institute for Cancer Immunotherapy, 513 Parnassus Avenue, San Francisco, CA 94143-0414, USA.
Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.
J Leukoc Biol. 2023 Jan 10;113(1):27-40. doi: 10.1093/jleuko/qiac003.
Natural killer (NK) cells are innate lymphocytes capable of mediating immune responses without prior sensitization. NK cells express Fc-gamma receptors (FcγRs) that engage the Fc region of IgG. Studies investigating the role of FcγRs on mouse NK cells have been limited due to lack specific reagents. In this study, we characterize the expression and biological consequences of activating mouse NK cells through their FcγRs. We demonstrate that most NK cells express the activating CD16 receptor, and a subset of NK cells also expresses the inhibitory CD32b receptor. Critically, these FcγRs are functional on mouse NK cells and can modulate antibody-mediated responses. We also characterized mice with conditional knockout alleles of Fcgr3 (CD16) or Fcgr2b (CD32b) in the NK and innate lymphoid cell (ILC) lineage. NK cells in these mice did not reveal any developmental defects and were responsive to cross-linking activating NK receptors, cytokine stimulation, and killing of YAC-1 targets. Importantly, CD16-deficient NK cells failed to induce antibody-directed cellular cytotoxicity of antibody-coated B-cell lymphomas in in vitro assays. In addition, we demonstrate the important role of CD16 on NK cells using an in vivo model of cancer immunotherapy using anti-CD20 antibody treatment of B-cell lymphomas.
自然杀伤 (NK) 细胞是先天淋巴细胞,能够在未经致敏的情况下介导免疫反应。NK 细胞表达 Fc-γ 受体 (FcγR),可与 IgG 的 Fc 区结合。由于缺乏特异性试剂,研究 NK 细胞 FcγR 作用的研究受到限制。在这项研究中,我们通过 NK 细胞的 FcγR 来描述其表达和生物学效应。我们证明大多数 NK 细胞表达激活型 CD16 受体,并且 NK 细胞的亚群还表达抑制型 CD32b 受体。重要的是,这些 FcγR 在 NK 细胞上具有功能,并且可以调节抗体介导的反应。我们还对 NK 和固有淋巴细胞 (ILC) 谱系中 Fcgr3(CD16)或 Fcgr2b(CD32b)条件性基因敲除小鼠进行了特征描述。这些小鼠中的 NK 细胞未显示出任何发育缺陷,并且对交联激活 NK 受体、细胞因子刺激和 YAC-1 靶细胞的杀伤反应敏感。重要的是,在体外试验中,缺乏 CD16 的 NK 细胞无法诱导抗体包被的 B 细胞淋巴瘤的抗体定向细胞毒性。此外,我们使用抗 CD20 抗体治疗 B 细胞淋巴瘤的癌症免疫治疗体内模型,证明了 CD16 在 NK 细胞中的重要作用。